Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.
A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say. To be sure, drugs such as$ノボ・ノルディスク(NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...
Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.
Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.
These are the top stocks as ranked by a growth model that scores companies based on a 50/50 weighting of their most recent quarterly year-on-year (YOY) percentage revenue growth and their most recent quarterly YOY earnings per share (EPS) growth. Both sales and earnings are critical factors in the success of a company. Therefore, ranking companies by only one growth metric makes a ranking susceptible to the accounting anomalies of that quarter (such as changes in tax law or...
Upgrades •$ボルグワーナー(BWA.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43) •$エクスペンシファイ(EXFY.US)$: BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20) •$グラブ・ホールディングス(GRAB.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $3 •$フーリハン・ローキー(HLI.US)$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95) •$JPモルガン・チェース(JPM.US)$: Berenberg Upgrades to Hold from Sell - PT ...
Upgrades •$テクニップFMC(FTI.US)$: Societe Generale Upgrades to uy from Hold - PT $10 •$ルルレモン・アスレティカ(LULU.US)$: Truist Securities Upgrades to Buy from Hold - PT $495 (from $390) •$ノースウェスタン(NWE.US)$: Barclays Upgrades to Equal Weight From Underweight - PT $62 (from $57) •$ポートランド・ジェネラル・エレクトリック(POR.US)$: Barclays Upgrades to EqualWeight From Underweight - PT $57 (from $53) •$プライススマート(PSMT.US)$: Scotiabank Upgrades to Sector Outperform Fro...
ペナンブラに関するコメント
コラムMedical-device Stock Selloff Caused by Ozempic Fears Has Gone Too Far—Now They're Rebounding
To be sure, drugs such as $ノボ・ノルディスク(NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...
コラムUS Top Gap Ups and Downs on 8/2: VRT, AZPN, DRVN, TEF and More
Gap Ups
1. $バーティブ・ホールディングス(VRT.US)$ - up 18.6%
2. $エリー・インデムニティー(ERIE.US)$ - up 8.7%
3. $アスペンテクノロジーインク(AZPN.US)$ - up 6.5%
4. $ペンスキー・オートモーティブ・グループ(PAG.US)$ - up 5.1%
5. $ヒューマナ(HUM.US)$ - up 3.7%
6. $テバ・ファーマスーティカル・インダストリーズ(TEVA.US)$ - up 3.7%
7. $エンコンパス・ヘルス(EHC.US)$ - up 3.0%
8. $エマソン・エレクトリック(EMR.US)$ - up 2.8...
Fastest-Growing Stocks
Both sales and earnings are critical factors in the success of a company. Therefore, ranking companies by only one growth metric makes a ranking susceptible to the accounting anomalies of that quarter (such as changes in tax law or...
コラムUS Top Rating Updates on 10/5: WMT, GS, NKE, ABNB and More
• $アバンター(AVTR.US)$ : Citigroup Upgrades to Buy from Neutral - PT $28
• $チャーチ・アンド・ドワイト(CHD.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $90)
• $コノコフィリップス(COP.US)$ : Erste Group Upgrades to Buy from Hold
• $フォード・モーター(F.US)$ : Morgan Stanley Upgrades to Overweight from Equal Weight - PT $14
• $シリコン・モーション・テクノロジー(SIMO.US)$ : Susquehanna Upgrades to Positive from Neutral - PT $108
• $ウォルマート(WMT.US)$ ...
コラムTop upgrades and downgrades on 7/18: JPM, GRAB, GM, KHC and more
• $ボルグワーナー(BWA.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $48 (from $43)
• $エクスペンシファイ(EXFY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $25 (from $20)
• $グラブ・ホールディングス(GRAB.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $3
• $フーリハン・ローキー(HLI.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $82 (from $95)
• $JPモルガン・チェース(JPM.US)$ : Berenberg Upgrades to Hold from Sell - PT ...
コラムTop upgrades and downgrades on 4/19
• $テクニップFMC(FTI.US)$ : Societe Generale Upgrades to uy from Hold - PT $10
• $ルルレモン・アスレティカ(LULU.US)$ : Truist Securities Upgrades to Buy from Hold - PT $495 (from $390)
• $ノースウェスタン(NWE.US)$ : Barclays Upgrades to Equal Weight From Underweight - PT $62 (from $57)
• $ポートランド・ジェネラル・エレクトリック(POR.US)$ : Barclays Upgrades to EqualWeight From Underweight - PT $57 (from $53)
• $プライススマート(PSMT.US)$ : Scotiabank Upgrades to Sector Outperform Fro...
まだコメントはありません